Acute Schizophrenia Clinical Trial
Official title:
A Multicenter, Placebo-controlled, Randomized, Double-blind, Parallel-group Comparison Trial to Investigate the Efficacy and Safety of Brexpiprazole Once-weekly (QW) Formulation in Patients With Acute Schizophrenia
Confirm the efficacy of the brexpiprazole QW formulation versus placebo for acute symptoms of schizophrenia
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01668797 -
Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia
|
Phase 3 | |
| Completed |
NCT00350467 -
A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia
|
Phase 3 | |
| Completed |
NCT03160521 -
Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia
|
Phase 3 | |
| Completed |
NCT01393613 -
Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia
|
Phase 3 | |
| Completed |
NCT01396421 -
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
|
Phase 3 | |
| Completed |
NCT00140166 -
Treatment of Acute Schizophrenia With Vitamin Therapy
|
Phase 4 | |
| Completed |
NCT01490086 -
RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
|
Phase 2 | |
| Unknown status |
NCT00838032 -
Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With Schizophrenia
|
Phase 4 |